世界の腫瘍放射線療法市場2021年-2030年:種類別(外部ビーム放射線療法、内部ビーム放射線療法)、用途別

【英語タイトル】Radiation Oncology Market By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Allied Market Researchが出版した調査資料(ALD22NV0037)・商品コード:ALD22NV0037
・発行会社(調査会社):Allied Market Research
・発行日:2022年7月
・ページ数:280
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥853,812見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD9,995 ⇒換算¥1,479,260見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社の本調査資料では、世界の腫瘍放射線療法市場規模が2021年7,794.4百万ドルから2030年15,231.2百万ドルに達し、2022年から2030年まで年平均7.8%成長すると予測しています。当書は、腫瘍放射線療法の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、種類別(外部ビーム放射線療法、内部ビーム放射線療法)分析、用途別(前立腺癌、乳癌、肺癌、頭頸部癌、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、BD、Isoray Inc.、Provision Healthcare、Varian Medical Systems, Inc.、Elekta AB、Accuray Incorporated、Mevion Medical Systems、IBA Worldwide、Nordion (Canada) Inc.、Panacea Medical Technologies Pvt. Ltdなどが含まれております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の腫瘍放射線療法市場規模:種類別
- 外部ビーム放射線療法の市場規模
- 内部ビーム放射線療法の市場規模
・世界の腫瘍放射線療法市場規模:用途別
- 前立腺癌における市場規模
- 乳癌における市場規模
- 肺癌における市場規模
- 頭頸部癌における市場規模
- その他用途における市場規模
・世界の腫瘍放射線療法市場規模:地域別
- 北米の腫瘍放射線療法市場規模
- ヨーロッパの腫瘍放射線療法市場規模
- アジア太平洋の腫瘍放射線療法市場規模
- 中南米・中東・アフリカの腫瘍放射線療法市場規模
・企業状況
・企業情報

The global radiation oncology market was valued at $7,794.4 million in 2021, and is anticipated to reach $15,231.2 million by 2030, growing at a CAGR of 7.8% from 2022 to 2030.
Radiation oncology is one of the treatment options for cancer along with surgery and chemotherapy. In radiation therapy, high energy protons are emitted into the effected part of the body, which stops the DNA replication and eventually death leads to the of cancer cells. Radiation therapy persists to be an an important part of treatment with 50% of cancer patients receiving it and with a contribution of 40% of the curative treatment.
According to WHO, cancer was one of the leading causes of deaths worldwide, counting for 10 million deaths in 2020, which is nearly one in every six deaths. Advancements like image guided and intensity modulated radiation therapy, digital imaging, and computer controlled linear accelerators have transformed radiation oncology over the past decade. These advancements have reduced the chances of many medical events and errors. The increase in sedentary lifestyle along with improper diet and lack of exercise are making patients prone to cancer.
In underdeveloped countries, extremely high treatment costs of cancer treatment are a serious issue. Infrastructure with a high level of technical advancement drives up costs. Despite the efforts of governments from other nations, contributions have not reached the bottom of the pyramid. Furthermore, technical improvements have resulted in additional problems such as device communication failures, software defects, and hardware failures, all of which hamper market growth. It is difficult for developing and underdeveloped countries to afford highly equipped radio oncology devices due to their high costs. Moreover, lack of adequate healthcare facilities along with lack of skilled surgeons in underdeveloped countries could hamper the market growth.
Rising mortality rate of cancer has been an important propeller to the market. The increasing number of cases will need a better treatment to the disease in future, and along with the cutting-edge technological advancement, it can be estimated that the market will be propelled in the forecasted period.
Healthcare Industries were favoured by the pandemic, however not every part was positively impacted. Many clinics across the world were converted into Covid-19 clinics to treat Covid patients. There was unavailability of hospital beds for cancer patients since Covid patients were taken on priority. Patients avoided visiting hospitals in fear contracting the infection. During the continuing COVID-19 situation, the Italian Association of Radiation and Clinical Oncology (AIRO), established a document to standardise radiotherapy operating practises [9] and conducted a focused nationwide survey.
The key players in the global radiation oncology market are Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems, IBA Worldwide, Nordion (Canada) Inc., BD, Isoray Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the radiation oncology market analysis from 2021 to 2030 to identify the prevailing radiation oncology market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the radiation oncology market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global radiation oncology market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type
● External Beam Radiation Therapy
● Internal Beam Radiation Therapy

By Application
● Prostate Cancer
● Breast Cancer
● Lung Cancer
● Head and Neck Cancer
● Colorectal Cancer
● Cervical Cancer
● Gynecological Cancer
● Others

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ United Kingdom
○ France
○ Spain
○ Italy
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest Of Asia Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ UAE
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ BD
○ Isoray Inc.
○ Provision Healthcare
○ Varian Medical Systems, Inc.
○ Elekta AB
○ Accuray Incorporated
○ Mevion Medical Systems
○ IBA Worldwide
○ Nordion (Canada) Inc.
○ Panacea Medical Technologies Pvt. Ltd

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Value Chain Analysis
3.8.Market Share Analysis
3.9.Regulatory Guidelines
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: RADIATION ONCOLOGY MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 External Beam Radiation Therapy
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Internal Beam Radiation Therapy
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: RADIATION ONCOLOGY MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Prostate Cancer
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Breast Cancer
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Lung Cancer
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Head and Neck Cancer
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Colorectal Cancer
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Cervical Cancer
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Gynecological Cancer
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
5.9 Others
5.9.1 Key market trends, growth factors and opportunities
5.9.2 Market size and forecast, by region
5.9.3 Market analysis by country
CHAPTER 6: RADIATION ONCOLOGY MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Type
6.2.3 North America Market size and forecast, by Application
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Type
6.2.4.1.2 Market size and forecast, by Application
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Type
6.2.4.2.2 Market size and forecast, by Application
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Type
6.2.4.3.2 Market size and forecast, by Application
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Type
6.3.3 Europe Market size and forecast, by Application
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Type
6.3.4.1.2 Market size and forecast, by Application
6.3.4.2 United Kingdom
6.3.4.2.1 Market size and forecast, by Type
6.3.4.2.2 Market size and forecast, by Application
6.3.4.3 France
6.3.4.3.1 Market size and forecast, by Type
6.3.4.3.2 Market size and forecast, by Application
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Type
6.3.4.4.2 Market size and forecast, by Application
6.3.4.5 Italy
6.3.4.5.1 Market size and forecast, by Type
6.3.4.5.2 Market size and forecast, by Application
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Type
6.3.4.6.2 Market size and forecast, by Application
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Type
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Type
6.4.4.1.2 Market size and forecast, by Application
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Type
6.4.4.2.2 Market size and forecast, by Application
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Type
6.4.4.3.2 Market size and forecast, by Application
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Type
6.4.4.4.2 Market size and forecast, by Application
6.4.4.5 Australia
6.4.4.5.1 Market size and forecast, by Type
6.4.4.5.2 Market size and forecast, by Application
6.4.4.6 Rest Of Asia Pacific
6.4.4.6.1 Market size and forecast, by Type
6.4.4.6.2 Market size and forecast, by Application
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Type
6.5.3 LAMEA Market size and forecast, by Application
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Type
6.5.4.1.2 Market size and forecast, by Application
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Type
6.5.4.2.2 Market size and forecast, by Application
6.5.4.3 UAE
6.5.4.3.1 Market size and forecast, by Type
6.5.4.3.2 Market size and forecast, by Application
6.5.4.4 South Africa
6.5.4.4.1 Market size and forecast, by Type
6.5.4.4.2 Market size and forecast, by Application
6.5.4.5 Rest of LAMEA
6.5.4.5.1 Market size and forecast, by Type
6.5.4.5.2 Market size and forecast, by Application
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 BD
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Isoray Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Provision Healthcare
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Varian Medical Systems, Inc.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Elekta AB
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Accuray Incorporated
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Mevion Medical Systems
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 IBA Worldwide
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Nordion (Canada) Inc.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Panacea Medical Technologies Pvt. Ltd
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments



★調査レポート[世界の腫瘍放射線療法市場2021年-2030年:種類別(外部ビーム放射線療法、内部ビーム放射線療法)、用途別] (コード:ALD22NV0037)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腫瘍放射線療法市場2021年-2030年:種類別(外部ビーム放射線療法、内部ビーム放射線療法)、用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆